Thinking about whether JBS might be undervalued? Let’s break down what’s going on beneath the surface and see if there could be an opportunity hiding in plain sight. JBS’s stock price has moved up by ...

Anthropic raised its growth forecasts by about 13% to 28% over the next three years and expects to generate up to $70B in ...

Xos strengthened its balance sheet by amending its outstanding $20 million Convertible Note, originally due August 11, 2025, ...

Get key insights from Orion S.A.'s Q3 2025 earnings call: cost actions, market outlook, cash flow targets, and strategic shifts.

Curious about whether Bristol-Myers Squibb is undervalued or could be a hidden gem? You're not alone, as plenty of investors ...

Anthropic this summer hiked its most optimistic growth forecasts by roughly 13% to 28% over the next three years and ...

Starting next week, departments will have to submit 90-day overtime projections and receive advanced approval.

Hapvida (HAPV3) declared a net profit of R$338 million on Wednesday night, but the third quarter of 2025 proved to be quite ...

At its investor day, Chevron Corporation (NYSE: CVX) outlined its five-year plan to 2030 and how it intends to deliver sustained cash flow growth, further strengthen its portfolio, advance power ...

Advanced modeling powered by artificial intelligence (AI) indicates that Montauban may be more than a reclamation or redevelopment story – it may be emerging as the nucleus of a potentially much ...

Wondering whether Accenture is a bargain or overpriced right now? You are not alone. A few smart valuation checks can help ...

Ever wondered if Lockheed Martin is priced just right, undervalued, or maybe a hidden gem in the defense sector? You are not ...